ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,865Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 5176

$1.12M Total Retail Price of All Prescriptions

Rank: 199 out of 5176

703 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 18,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,385 1,189 1 2
SIMVASTATIN 1,256 1,076 2 1
OMEPRAZOLE 1,035 854 3 3
HYDROCHLOROTHIAZIDE 833 728 4 10
MELOXICAM 518 467 5 53
METFORMIN HCL 495 345 6 7
LOSARTAN-HYDROCHLOROTHIAZIDE 462 401 7 35
ZOLPIDEM TARTRATE 417 331 8 17
ALENDRONATE SODIUM 404 346 9 18
IBUPROFEN 358 207 10 72
TAMSULOSIN HCL 354 337 11 20
CARVEDILOL 347 306 12 24
LOSARTAN POTASSIUM 337 281 13 14
LISINOPRIL 312 254 14 5
FLUTICASONE PROPIONATE 306 254 15 38
DIOVAN HCT 303 247 16 39
VENTOLIN HFA 291 226 17 64
NEXIUM 280 198 18 16
FUROSEMIDE 278 246 19 8
ATENOLOL 274 234 20 12
METOPROLOL SUCCINATE 273 239 21 11
GLYBURIDE-METFORMIN HCL 269 226 R 22 76
SINGLE USE SWAB 262 233 10 23 108
CRESTOR 255 208 24 15
ACTOS 249 227 25 85
NIFEDIPINE ER 239 214 26 48
LEVOTHYROXINE SODIUM 238 194 27 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 184 28 49
ENALAPRIL MALEATE 219 163 29 22
PLAVIX 215 193 30 29
NAPROXEN 211 137 31 95
MECLIZINE HCL 204 186 32 81
GLIPIZIDE XL 199 165 33 83
RANITIDINE HCL 194 184 34 36
GLIPIZIDE ER 194 172 34 117
METOPROLOL TARTRATE 192 151 36 6
AMLODIPINE BESYLATE-BENAZEPRIL 191 152 37 55
LOVAZA 175 170 38 43
DONEPEZIL HCL 173 158 39 28
ADVAIR DISKUS 164 127 40 32
GABAPENTIN 162 126 41 21
DIOVAN 152 143 42 19
JANUVIA 150 131 43 25
ATENOLOL-CHLORTHALIDONE 144 116 44 161
CLOPIDOGREL 144 122 44 26
ALCOHOL PREP PADS 141 134 46 198
ATORVASTATIN CALCIUM 140 111 47 9
SINGULAIR 134 104 48 62
FINASTERIDE 129 119 49 69
DILTIAZEM 24HR CD 112 104 50 119
SERTRALINE HCL 111 92 51 30
DICLOFENAC SODIUM 108 95 52 160
WARFARIN SODIUM 99 91 53 13
FAMOTIDINE 95 60 54 58
LANTUS 92 70 55 66
DESOXIMETASONE 92 84 55 278
EXFORGE 88 78 57 126
RANEXA 85 70 58 167
CROMOLYN SODIUM 83 76 59 332
INSULIN SYRINGE 83 50 59 137
GEMFIBROZIL 82 82 61 139
GLYBURIDE 80 69 R 62 67
JANUMET 78 38 63 77
AMMONIUM LACTATE 78 68 63 91
AVODART 75 75 65 107
ENALAPRIL-HYDROCHLOROTHIAZIDE 75 47 65 212
PATADAY 75 56 65 220
CLOTRIMAZOLE-BETAMETHASONE 73 63 68 94
GLIMEPIRIDE 73 56 68 37
MICARDIS HCT 72 72 70 180
RAMIPRIL 71 51 71 50
PROAIR HFA 71 45 71 60
LACLOTION 70 58 73 299
NAMENDA 69 69 74 47
ALCOHOL SWABS 64 59 75 115
LEVEMIR FLEXPEN 62 45 76 200
TRAZODONE HCL 60 49 77 71
COREG CR 59 59 78 275
MONTELUKAST SODIUM 58 35 79 123
LANTUS SOLOSTAR 55 31 80 70
EVISTA 53 53 81 65
PATANOL 53 40 81 158
ISOSORBIDE MONONITRATE ER 53 52 81 44
VALSARTAN-HYDROCHLOROTHIAZIDE 53 41 81 292
PIOGLITAZONE HCL 52 43 R 85 237
FOSINOPRIL SODIUM 52 50 85 105
SPIRIVA 51 48 87 54
POTASSIUM CHLORIDE 50 46 88 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.